IL6 and neoplasm: The same study shows that MSCs contribute to the tumor microenvironment by secretive immunosuppressive and tumor-promoting factors, HFG, EGF, and IL-6, indicating that inflammation-induced hypomethylation can activate genes that support MSC migration and enhance immunosuppressive functions, aiding in tumor progression.